As scientists continue to acquire immense amounts of genomic and biochemical data from various organisms, they routinely find themselves confronted by proteins of known structure but enigmatic function—and resolving those mysteries may require a chemical-based ‘fishing expedition’.
“The discovery of small molecules that bind to and disrupt the function of a specific target is an important step in chemical biology, especially for poorly characterized proteins,” explains Isao Miyazaki, a researcher with Hiroyuki Osada’s team at the RIKEN Advanced Science Institute in Wako. “We call these small molecules ‘bioprobes’.”
Recent work from Miyazaki and Osada demonstrates a highly effective strategy for identifying such bioprobes, which they have used to identify inhibitors of the human pirin protein1. Pirin is conserved across a diverse array of organisms, and has been tentatively linked to cancer malignancy in humans; however, little is known about how this protein might govern tumor progression.
The investigators produced glass slides containing a large array of small molecules, which they then treated with cellular extracts containing pirin protein fused to DsRed, a fluorescent tag. By identifying the spots selectively highlighted by the labeled protein, they were able to zoom in on a candidate molecule with apparently high specificity and binding affinity for pirin, which they named triphenyl compound A (TPh A).
High-resolution structural analysis demonstrated that TPh A inserts itself deeply within the pirin protein, and Miyazaki sees this as proof of the utility of their screening strategy. “There has been a question of whether ligands identified using chemical array approaches typically bind at shallow surfaces,” he says. “Our study confirms that chemical array methods can identify molecules that bind to buried pockets in proteins.”
Accordingly, TPh A appears to act as an effective functional inhibitor. Melanoma cells treated with this compound showed a marked reduction in cell migration, and this effect appears to arise from TPh A-mediated disruption of the interaction between pirin and the cancer-related protein Bcl3. By analyzing cellular gene expression profiles, the researchers subsequently uncovered evidence that pirin and Bcl3 collaborate to switch on the SNAI2 gene, which is known to contribute to tumor progression and metastatic growth.
These findings demonstrate the potential of bioprobe screening as a strategy for uncovering hidden protein functions. Miyazaki and Osada anticipate that TPh A will provide a valuable tool for future investigations of the role of pirin in other cancers and may even prove useful for studying related proteins from other organisms.
The corresponding author for this highlight is based at the Antibiotics Laboratory, RIKEN Advanced Science Institute
1. Miyazaki, I., Simizu, S., Okumura, H., Takagi, S. & Osada, H. A small-molecule inhibitor shows that pirin regulates migration of melanoma cells. Nature Chemical Biology 6, 667–673 (2010).
gro-pr | Research asia research news
Closing the carbon loop
08.12.2016 | University of Pittsburgh
Newly discovered bacteria-binding protein in the intestine
08.12.2016 | University of Gothenburg
In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.
Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...
Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...
A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.
Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...
In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.
“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...
The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.
The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...
16.11.2016 | Event News
01.11.2016 | Event News
14.10.2016 | Event News
08.12.2016 | Life Sciences
08.12.2016 | Physics and Astronomy
08.12.2016 | Materials Sciences